(Q44154127)

30 November 2017

title

Immunosuppressant pharmacodynamics on peripheral-blood mononuclear cells from patients with ulcerative colitis (English)

1 reference

30 November 2017

1 reference

1 reference

Toshihiko Hirano

1

1 reference

30 November 2017

Takao Akashi

2

1 reference

30 November 2017

Toshimasa Kido

3

1 reference

30 November 2017

Kitaro Oka

4

1 reference

30 November 2017

Taisei Shiratori

5

1 reference

30 November 2017

Masaaki Miyaoka

6

1 reference

30 November 2017

publication date

1 July 2002

1 reference

International Immunopharmacology

30 November 2017

published in

1 reference

30 November 2017

volume

2

1 reference

30 November 2017

issue

8

1 reference

30 November 2017

page(s)

1055-1063

1 reference

Cyclosporin in ulcerative colitis

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Lymphocyte sensitivity to cyclosporine and tacrolimus in chronic renal failure patients and clinical significance in renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Individual variations in lymphocyte-responses to glucocorticoids in patients with bronchial asthma: comparison of potencies for five glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Prednisone and methylprednisolone disposition in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

A comparison of prednisolone and methylprednisolone for renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Measuring the response to glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900077-2

7 January 2021

10.1016/S1567-5769(02)00077-2

Identifiers

DOI

1 reference

30 November 2017

1 reference